Skip to main content
. Author manuscript; available in PMC: 2020 Jun 1.
Published in final edited form as: Clin Transplant. 2019 May 7;33(6):e13568. doi: 10.1111/ctr.13568

Table 1:

Rejection-free survival for each treatment group.

Treatment Group Rejection-Free Survival (days)
No Treatment (Historic Control) 5, 6, 7, 7, 9
Group 1: Abatacept + Steroid 36, >366, >366
Group 2: Abatacept + Methotrexate 9, 66, >238
Group 3: Abatacept + Steroid + Methotrexate 30, 65, 224, >391